Physician profile
David Matthew Harris
NPI 1174695050
$936.44
in general payments reported to CMS, 2019-2025
9 companies · $224 in 2025
The $224 reported for 2025 was more than what 77% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $14.89 · 2021: $32.70 · 2022: $43.13 · 2023: $394 · 2024: $228 · 2025: $224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $846.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $845.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $537.44 | 2023-2025 | |
| Nobel Biocare USA | $179.68 | 2022-2023 | Nobelactive |
| Dmg America LLC | $93.02 | 2023 | |
| 3m Company | $31.16 | 2020-2023 | Scotchbond Universal Plus, 3m Filtek, Filtek |
| Voco America INC. | $23.62 | 2024 | Meron Plus Qm, Grandio So Heavy Flow |
| Align Technology, INC. | $20.18 | 2023 | Itero Element Flex |
| Solventum Corporation | $18.64 | 2024 | Paradigm Temporization, 3m Scotchbond, 3m Filtek |
| Orapharma, A Division of Bausch Health US, LLC | $16.82 | 2021 | |
| Dentsply Sirona INC | $15.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.